Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

Clinical trial NCT03247712 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03247712
Sponsor: Providence Health & Services
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2018-01-15
Primary completion: 2020-02-13
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.